Wiley, BJOG: An International Journal of Obstetrics and Gynaecology, (121), p. 53-61, 2014
Full text: Download
There is an urgent need for technologies to prevent sexual acquisition of HIV infection in young women in sub-Saharan Africa. After two decades of eleven pivotal trials of seven products, antiretroviral-based topical microbicides are showing promise. Building on the CAPRISA 004 trial findings, several trials of new antiviral agents, novel delivery mechanisms and combination/multi-purpose products that address challenges of adherence and meet the sexual and reproductive health needs of men and women, including preventing HIV infection, are underway.